Answer
The apparent elimination half-life of emicizumab after repeated subcutaneous injections in patients with haemophilia A is 26.8 days.
Sources for this answer
- Hemlibra 30 mg/mL and 150 mg/mL Solution for InjectionRoche Products Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 17Document updated
Sources checked